Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Mt. Pleasant, South Carolina Clinical Trials

A listing of Mt. Pleasant, South Carolina clinical trials actively recruiting patient volunteers.

RESULTS

Found (551) clinical trials

Gout currently affects approximately 8 million Americans. Febuxostat is an approved medication for the chronic management of Gout. The purpose of this study is to evaluate the efficacy and safety of febuxostat XR (extended release) in comparison with febuxostat IR (immediate release) in people who suffer from Gout. If you ...

Phase N/A

1.13 miles

Learn More »

You may qualify for a research study which evaluates the effectiveness and safety of an investigational medication given by injection in individuals who suffer from moderate to severe headaches and migraines. Volunteers will receive 3 doses of the study medication or placebo. This study will access the change in migraine ...

Phase N/A

1.13 miles

Learn More »

The study is evaluating the effectiveness of an investigational gel that is delivered with a pump/cap applicator for the treatment of low testosterone symptoms (such as low sex drive, low energy, mood problems, loss of muscle mass). Men who currently treat or do not treat their low testosterone are welcome ...

Phase N/A

1.13 miles

Learn More »

Coastal Carolina Research Center is evaluating the safety, tolerability, and immune response of an investigational, seasonal flu vaccine in generally healthy men and women. If you qualify for participation, you can expect 6 clinic visits and one phone call for collection of safety data over 12 months. If you are ...

Phase N/A

1.13 miles

Learn More »

A research study is evaluating an investigational medication for chronic heart failure. This research study may be an option if you: Are at least 18 years of age Have been taking medication (standard therapy) for heart failure Have been hospitalized in the last 6 months OR have received IV diuretics ...

Phase N/A

1.13 miles

Learn More »

A research study is evaluating the combination of one investigational medication with two FDA-approved medications for high cholesterol. This research study may be an option if you: Are at least 18 years of age or older Have a history of elevated LDL (“bad” cholesterol) levels Are able to stop use ...

Phase N/A

1.13 miles

Learn More »

A research study is evaluating an investigational medication for high cholesterol when added to an FDA-approved PCSK9 inhibitor (cholesterol lowering therapy). This research study may be an option if you: Are at least 18 years of age Have high LDL (“bad” cholesterol) levels between 70 and 160 Do not have ...

Phase N/A

1.13 miles

Learn More »

The purpose of this study is to assess the efficacy and safety of ALD403 in the prevention of migraine headache in chronic migraineurs.

Phase N/A

1.13 miles

Learn More »

This study will evaluate the efficacy, safety, and tolerability of two doses of rapastinel, 225 milligrams (mg) and 450 mg, compared to placebo adjunctive to antidepressant therapy (ADT) in patients with major depressive disorder (MDD) who have a partial response to ADT.

Phase

1.13 miles

Learn More »

This study will evaluate the efficacy, safety and tolerability of rapastinel 450 milligrams (mg) intravenous (IV) once weekly or once every 2 weeks versus placebo as an adjunctive treatment to ongoing anti-depressive therapy (ADT) in the prevention of relapse in participants with Major Depressive Disorder (MDD).

Phase

1.13 miles

Learn More »